ProShare Advisors’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,840
Closed -$19K 1831
2022
Q2
$19K Sell
12,840
-30,646
-70% -$45.3K ﹤0.01% 1772
2022
Q1
$50K Buy
43,486
+8,868
+26% +$10.2K ﹤0.01% 2116
2021
Q4
$87K Buy
34,618
+1,270
+4% +$3.19K ﹤0.01% 2221
2021
Q3
$171K Sell
33,348
-8,268
-20% -$42.4K ﹤0.01% 1825
2021
Q2
$346K Buy
41,616
+3,697
+10% +$30.7K ﹤0.01% 1793
2021
Q1
$330K Buy
37,919
+2,482
+7% +$21.6K ﹤0.01% 1746
2020
Q4
$385K Buy
35,437
+8,146
+30% +$88.5K ﹤0.01% 1427
2020
Q3
$326K Sell
27,291
-980
-3% -$11.7K ﹤0.01% 1131
2020
Q2
$454K Buy
28,271
+10,272
+57% +$165K ﹤0.01% 995
2020
Q1
$279K Sell
17,999
-13,664
-43% -$212K ﹤0.01% 903
2019
Q4
$779K Sell
31,663
-1,824
-5% -$44.9K ﹤0.01% 887
2019
Q3
$345K Buy
33,487
+670
+2% +$6.9K ﹤0.01% 1156
2019
Q2
$412K Sell
32,817
-568
-2% -$7.13K ﹤0.01% 1093
2019
Q1
$414K Buy
33,385
+275
+0.8% +$3.41K ﹤0.01% 1103
2018
Q4
$204K Sell
33,110
-1,633
-5% -$10.1K ﹤0.01% 1366
2018
Q3
$368K Sell
34,743
-1,351
-4% -$14.3K ﹤0.01% 1255
2018
Q2
$489K Sell
36,094
-2,201
-6% -$29.8K ﹤0.01% 1132
2018
Q1
$680K Sell
38,295
-6,302
-14% -$112K ﹤0.01% 978
2017
Q4
$560K Buy
44,597
+8,830
+25% +$111K ﹤0.01% 1076
2017
Q3
$681K Buy
35,767
+2,168
+6% +$41.3K 0.01% 850
2017
Q2
$507K Sell
33,599
-1,996
-6% -$30.1K 0.01% 960
2017
Q1
$610K Sell
35,595
-9,193
-21% -$158K 0.01% 940
2016
Q4
$542K Buy
44,788
+4,299
+11% +$52K 0.01% 1040
2016
Q3
$398K Sell
40,489
-7,033
-15% -$69.1K 0.01% 1040
2016
Q2
$487K Buy
47,522
+364
+0.8% +$3.73K 0.01% 977
2016
Q1
$572K Buy
47,158
+9,394
+25% +$114K 0.01% 937
2015
Q4
$605K Buy
37,764
+3,466
+10% +$55.5K 0.01% 951
2015
Q3
$441K Sell
34,298
-2,290
-6% -$29.4K 0.01% 974
2015
Q2
$878K Buy
36,588
+6,586
+22% +$158K 0.01% 841
2015
Q1
$563K Buy
30,002
+4,624
+18% +$86.8K 0.01% 1118
2014
Q4
$479K Buy
25,378
+2,987
+13% +$56.4K 0.01% 1225
2014
Q3
$607K Sell
22,391
-3,979
-15% -$108K 0.01% 1288
2014
Q2
$821K Sell
26,370
-5,511
-17% -$172K 0.01% 1258
2014
Q1
$726K Buy
31,881
+18,986
+147% +$432K 0.01% 1566
2013
Q4
$268K Buy
+12,895
New +$268K ﹤0.01% 1196